Strike Pharma

Uppsala, Sweden

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).

$4.8M raised

Feb 2022

Venture - Series Unknown

Biotechnology Pharmaceutical Precision Medicine Therapeutics

Top Investors

Almi Invest EIR Ventures Flerie Invest

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Strike Pharma

How much funding has Strike Pharma raised?

Strike Pharma has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2022.

Who are Strike Pharma's investors?

Strike Pharma's investors include Almi Invest, EIR Ventures, Flerie Invest.

Where is Strike Pharma headquartered?

Strike Pharma is headquartered in Uppsala, Sweden.

What does Strike Pharma do?

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).

What stage is Strike Pharma at?

Strike Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 22, 2022.

MLA

"Strike Pharma — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/strike-pharma. Accessed July 1, 2026.

APA

VCBacked. (2022). Strike Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/strike-pharma

Wikipedia (cite web)

{{cite web |title=Strike Pharma — Funding & Investors |url=https://www.vcbacked.co/company/strike-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 22, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K